Replies to post #757785 on NorthWest Biotherapeutics Inc (NWBO)

[Bright Boy]

GGB,

Without naming Oncovir, I think we would be safe to assume that the only TLR that we/UCLA or anyone else that NWBO is associated with in various trials is Poly-ICLC. That's the only one that we know of the works and I know the company would not "In license" a product that doesn't work and everyone else knows that too. Good question.

Cheers,

BB

[dennisdave]

Hiltonol® IS a TLR antagonist, right?

Most likely which sucks because I had hoped they have entered in an agreement with a big pharma for that joint trial.

NWBO needs at least $500 million for all their idiotic plans. Now I understand why LP does not want a CFO around to tell her she is delusional

NWBO is pretending to be a big pharma in the 10K and 10Q with their loud mouth while running on fumes.